Canada Pension Plan Investment Board
RPRX icon

Canada Pension Plan Investment Board’s Royalty Pharma RPRX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.6M Buy
367,810
+318,500
+646% +$16.6M 0.01% 545
2026
Q1 		$2.37M Buy
49,310
+34,600
+235% +$1.52M ﹤0.01% 882
2025
Q4 		$568K Buy
14,710
+14,700
+147,000% +$561K ﹤0.01% 1257
2025
Q3 		$353 Sell
10
-569,185
-100% -$20.6M ﹤0.01% 1339
2025
Q2 		$20.5M Sell
569,195
-84,803
-13% -$2.81M 0.02% 474
2025
Q1 		$20.4M Sell
653,998
-151,617
-19% -$4.81M 0.02% 450
2024
Q4 		$20.6M Buy
805,615
+39,070
+5% +$1.04M 0.02% 456
2024
Q3 		$21.7M Sell
766,545
-18,020
-2% -$499K 0.02% 427
2024
Q2 		$20.7M Sell
784,565
-139,074
-15% -$3.86M 0.02% 428
2024
Q1 		$28.1M Buy
923,639
+45,839
+5% +$1.35M 0.03% 388
2023
Q4 		$24.7M Buy
877,800
+135,600
+18% +$3.73M 0.03% 372
2023
Q3 		$20.1M Buy
742,200
+82,000
+12% +$2.44M 0.03% 386
2023
Q2 		$20.3M Buy
660,200
+187,700
+40% +$6.36M 0.03% 373
2023
Q1 		$17M Buy
472,500
+467,945
+10,273% +$17.4M 0.03% 380
2022
Q4 		$180K Sell
4,555
-135,100
-97% -$5.64M ﹤0.01% 989
2022
Q3 		$5.61M Buy
139,655
+31,000
+29% +$1.32M 0.01% 511
2022
Q2 		$4.57M Sell
108,655
-4,600
-4% -$189K 0.01% 548
2022
Q1 		$4.41M Buy
113,255
+10,844
+11% +$426K 0.01% 622
2021
Q4 		$4.08M Sell
102,411
-31,759
-24% -$1.23M ﹤0.01% 745
2021
Q3 		$4.85M Buy
134,170
+133,175
+13,384% +$5.18M 0.01% 686
2021
Q2 		$41K Sell
995
-151,405
-99% -$6.44M ﹤0.01% 1076
2021
Q1 		$6.65M Buy
152,400
+44,100
+41% +$2.09M 0.01% 590
2020
Q4 		$5.42M Hold
108,300
– – 0.01% 600
2020
Q3 		$4.56M Buy
+108,300
New +$4.65M 0.01% 510

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Canada Pension Plan Investment Board's RPRX Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Royalty Pharma (RPRX) stake by 646% in Q2 2026, buying an estimated $16.6M and bringing the position to 367,810 shares worth $20.6M. The position accounts for 0.01% of the portfolio, ranked #545.

Canada Pension Plan Investment Board first reported a position in RPRX in Q3 2020 and has held it in 24 quarters since. The position peaked at $28.1M in Q1 2024. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Canada Pension Plan Investment Board held 367,810 shares of Royalty Pharma worth $20.6M as of Q2 2026.
  • Canada Pension Plan Investment Board bought 318,500 Royalty Pharma shares in Q2 2026, an estimated $16.6M.
  • Royalty Pharma made up 0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #545 holding.
  • Canada Pension Plan Investment Board first reported a position in Royalty Pharma in Q3 2020 and has held it in 24 quarters since.
  • Canada Pension Plan Investment Board's Royalty Pharma position peaked at $28.1M in Q1 2024.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.